EMERGENT BIOSOLUTIONS INC. (EBS) Capital expenditures 2016–2025
EMERGENT BIOSOLUTIONS INC. (EBS) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$13.8MFY2025 · since FY2016: $76.2M → $13.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $13.8M | -39.7% |
| FY2024 | $22.9M | -55.6% |
| FY2023 | $51.6M | -55.4% |
| FY2022 | $115.8M | -48.3% |
| FY2021 | $224.1M | +57.9% |
| FY2020 | $141.9M | +63.3% |
| FY2019 | $86.9M | +20.5% |
| FY2018 | $72.1M | +31.6% |
| FY2017 | $54.8M | -28.1% |
| FY2016 | $76.2M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice